Globus Medical, Inc. Reports Full Year and Fourth Quarter 2012 Results

Published: Feb 28, 2013

Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced its financial results for the year and fourth quarter ended December 31, 2012.

Full Year 2012:

• Worldwide sales were $386.0 million, up 16.4% over 2011
• Net income increased 21.5% to $73.8 million compared to $60.8 million in 2011
• 2012 earnings per fully diluted share increased 19.4% to $0.80 compared to $0.67 in 2011
• Non-GAAP Adjusted EBITDA was 35.4% of sales, compared to 35.8% in 2011

Back to news